<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-18T23:20:33+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>“这次没谈成，回去只能把公司卖掉了！”遭遇腰斩降价的药企，这个冬天，难了</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/QBaIVJAqhefCMTaZIXT7FA</id>
    <link href="https://mp.weixin.qq.com/s/QBaIVJAqhefCMTaZIXT7FA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>总点击50万的文章背后，我们看到了患者的无奈和药价谈判的真实意义！</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/YE3cof0QK8KTCr52NQGpdA</id>
    <link href="https://mp.weixin.qq.com/s/YE3cof0QK8KTCr52NQGpdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020全球最大生物医药IPO！荣昌生物共募资5.9亿美元</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/AaWfrdkyhbEMaLCokyQBvA</id>
    <link href="https://mp.weixin.qq.com/s/AaWfrdkyhbEMaLCokyQBvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>腾盛博药研发战略取得重大进展</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/OweY6BKAoZPFVVij7jH07Q</id>
    <link href="https://mp.weixin.qq.com/s/OweY6BKAoZPFVVij7jH07Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞冲击6000亿！本土豪门、生物新贵、MNC的PD-1“权力游戏”,高潮才刚开始……</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/E-yeq50YnOQORbUs7fx0ew</id>
    <link href="https://mp.weixin.qq.com/s/E-yeq50YnOQORbUs7fx0ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个1类新药获批，这家药企正式步入创新药时代</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/QE8ZLWUV5lzNMzQ_AvpuEQ</id>
    <link href="https://mp.weixin.qq.com/s/QE8ZLWUV5lzNMzQ_AvpuEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百洋医药商业化平台进阶，与安斯泰来达成进口新药合作意向</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/Doo1jZG3IqlmLg-6ryvqzg</id>
    <link href="https://mp.weixin.qq.com/s/Doo1jZG3IqlmLg-6ryvqzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>支架集采后该怎么办？如何保证用量？医保局规定来了！</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/XMvz2udbE2QbXN23t7QUVg</id>
    <link href="https://mp.weixin.qq.com/s/XMvz2udbE2QbXN23t7QUVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判DAY3：恒瑞PD-1大降超80%，4个适应证全进医保，K药、O药没进？</title>
    <updated>2020-12-16T19:24:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/-0RqOiY_AGcnTD7q89WulQ</id>
    <link href="https://mp.weixin.qq.com/s/-0RqOiY_AGcnTD7q89WulQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产创新药爆发：重大新药创制已有60款本土药获批！但创新还有这些挑战！</title>
    <updated>2020-12-16T19:24:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/L7OCUkoN7I96XrJu7uYsKg</id>
    <link href="https://mp.weixin.qq.com/s/L7OCUkoN7I96XrJu7uYsKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【中国中药65周年】倒计时3天！您将见证一场来自中药行业的云盛会！</title>
    <updated>2020-12-16T19:24:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/Cvawza10JpwSDjG4c08B0g</id>
    <link href="https://mp.weixin.qq.com/s/Cvawza10JpwSDjG4c08B0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判DAY2：AZ、杨森、再鼎已至。PD-1谈判前，恒瑞再破5000亿，百济、君实皆涨</title>
    <updated>2020-12-15T21:44:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/KE9W3GuQ05MmRrWqtg1dkw</id>
    <link href="https://mp.weixin.qq.com/s/KE9W3GuQ05MmRrWqtg1dkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代伟大中国创新药企长什么样？</title>
    <updated>2020-12-15T21:44:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ZTL-xsn8tcmhiUR0SwN8bg</id>
    <link href="https://mp.weixin.qq.com/s/ZTL-xsn8tcmhiUR0SwN8bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>打开获批20个适应证的8个PD-(L)1的正确方式</title>
    <updated>2020-12-15T21:44:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ntNnGuCaXQFG8_pLJv6hOQ</id>
    <link href="https://mp.weixin.qq.com/s/ntNnGuCaXQFG8_pLJv6hOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判DAY1：降幅超预期，多为独家品种，涉诺华、礼来。PD-1或在第三天</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/2rhvxukVFpLpVgdchHt9Vw</id>
    <link href="https://mp.weixin.qq.com/s/2rhvxukVFpLpVgdchHt9Vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访亚盛医药首席商务运营官祝刚：港股原创小分子第一股的商业经</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/SPvSVI_7vJQAm0D3M9f9cg</id>
    <link href="https://mp.weixin.qq.com/s/SPvSVI_7vJQAm0D3M9f9cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>氟唑帕利的前世今生——恒瑞医药李心博士专访</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/ScEkC5MQHvMvy81FT3JEmw</id>
    <link href="https://mp.weixin.qq.com/s/ScEkC5MQHvMvy81FT3JEmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>聚产业力量，创产业未来 ——中国医药产业链首个品牌服务商联盟发起成立</title>
    <updated>2020-12-14T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/FomOK7F5AfxYIssUPBPrWQ</id>
    <link href="https://mp.weixin.qq.com/s/FomOK7F5AfxYIssUPBPrWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康豪掷2500亿拟收购罕见病巨头，今年最大收购！</title>
    <updated>2020-12-13T20:48:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/pVNd4NBAno7zFPOMa8jq7g</id>
    <link href="https://mp.weixin.qq.com/s/pVNd4NBAno7zFPOMa8jq7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3800亿市值京东健康，来看看10万亿的亚马逊如何布局医药健康！</title>
    <updated>2020-12-13T20:48:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/vbBj1ryM4zgl5SgvX6KBLA</id>
    <link href="https://mp.weixin.qq.com/s/vbBj1ryM4zgl5SgvX6KBLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>